Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

JP Morgan Maintains Overweight on Biohaven, Raises Price Target to $32

Author: Benzinga Newsdesk | November 20, 2023 12:08pm
JP Morgan analyst Tessa Romero maintains Biohaven (NYSE:BHVN) with a Overweight and raises the price target from $26 to $32.

Posted In: BHVN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist